Literature DB >> 14764738

Respective roles of decay-accelerating factor and CD59 in circumventing glomerular injury in acute nephrotoxic serum nephritis.

Feng Lin1, David J Salant, Howard Meyerson, Steven Emancipator, B Paul Morgan, M Edward Medof.   

Abstract

Decay-accelerating factor (DAF or CD55) and CD59 are regulators that protect self cells from C3b deposition and C5b-9 assembly on their surfaces. Their relative roles in protecting glomeruli in immune-mediated renal diseases in vivo are unknown. We induced nephrotoxic serum (NTS) nephritis in Daf1(-/-), CD59a(-/-), Daf1(-/-)CD59a(-/-), and wild-type (WT) mice by administering NTS IgG. After 18 h, we assessed proteinuria, and performed histological, immunohistochemical, and electron microscopic analyses of kidneys. Twenty-four mice in each group were studied. Baseline albuminuria in the Daf1(-/-), CD59a(-/-), and Daf1(-/-)CD59a(-/-) mice was 82, 83, and 139 as compared with 92 microg/mg creatinine in the WT controls (p > 0.1). After NTS, albuminuria in CD59a(-/-) and WT mice (186 +/- 154 and 183 +/- 137 microg/mg creatinine, p > 0.1) was similar. In contrast, Daf1(-/-) mice developed severe albuminuria (378 +/- 520, p < 0.05) that was further exacerbated in Daf1(-/-)CD59a(-/-) mice (577 +/- 785 micro g/mg creatinine, p < 0.05). Glomerular histology showed essentially no infiltrating leukocytes in any group. In contrast, electron microscopy revealed prominent podocyte foot process effacement in Daf1(-/-) mice with more widespread and severe damage in the double knockouts compared with only mild focal changes in CD59a(-/-) or WT mice. In all animals, deposition of administered (sheep) NTS Ig was equivalent. This contrasted with marked deposition of both C3 and C9 in Daf1(-/-)CD59a(-/-) and Daf1(-/-) mice, which was evident as early as 2 h post-NTS injection. The results support the proposition that in autoantibody-mediated nephritis, DAF serves as the primary barrier to classical pathway-mediated injury, while CD59 limits consequent C5b-9-mediated cell damage.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14764738     DOI: 10.4049/jimmunol.172.4.2636

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  19 in total

Review 1.  Experimental membranous nephropathy redux.

Authors:  Andrey V Cybulsky; Richard J Quigg; David J Salant
Journal:  Am J Physiol Renal Physiol       Date:  2005-10

Review 2.  Review: Complement and its regulatory proteins in kidney diseases.

Authors:  Allison M Lesher; Wen-Chao Song
Journal:  Nephrology (Carlton)       Date:  2010-10       Impact factor: 2.506

3.  Sublytic C5b-9 complexes induce apoptosis of glomerular mesangial cells in rats with Thy-1 nephritis through role of interferon regulatory factor-1-dependent caspase 8 activation.

Authors:  Lisha Liu; Wen Qiu; Hui Wang; Yan Li; Jianbo Zhou; Mei Xia; Kai Shan; Rongrong Pang; Ying Zhou; Dan Zhao; Yingwei Wang
Journal:  J Biol Chem       Date:  2012-03-15       Impact factor: 5.157

Review 4.  Mechanisms of immune-deposit formation and the mediation of immune renal injury.

Authors:  Masaomi Nangaku; William G Couser
Journal:  Clin Exp Nephrol       Date:  2005-09       Impact factor: 2.801

5.  The membrane attack pathway of complement drives pathology in passively induced experimental autoimmune myasthenia gravis in mice.

Authors:  B P Morgan; J Chamberlain-Banoub; J W Neal; W Song; M Mizuno; C L Harris
Journal:  Clin Exp Immunol       Date:  2006-11       Impact factor: 4.330

Review 6.  Essential roles of gangliosides in the formation and maintenance of membrane microdomains in brain tissues.

Authors:  Yuhsuke Ohmi; Yuki Ohkawa; Yoshio Yamauchi; Orie Tajima; Keiko Furukawa; Koichi Furukawa
Journal:  Neurochem Res       Date:  2012-04-10       Impact factor: 3.996

7.  Transient receptor potential channel 6 (TRPC6) protects podocytes during complement-mediated glomerular disease.

Authors:  Andreas D Kistler; Geetika Singh; Mehmet M Altintas; Hao Yu; Isabel C Fernandez; Changkyu Gu; Cory Wilson; Sandeep Kumar Srivastava; Alexander Dietrich; Katherina Walz; Dontscho Kerjaschki; Phillip Ruiz; Stuart Dryer; Sanja Sever; Amit K Dinda; Christian Faul; Jochen Reiser
Journal:  J Biol Chem       Date:  2013-11-05       Impact factor: 5.157

8.  Focal and segmental glomerulosclerosis induced in mice lacking decay-accelerating factor in T cells.

Authors:  Lihua Bao; Mark Haas; Jeffrey Pippin; Ying Wang; Takashi Miwa; Anthony Chang; Andrew W Minto; Miglena Petkova; Guilin Qiao; Wen-Chao Song; Charles E Alpers; Jian Zhang; Stuart J Shankland; Richard J Quigg
Journal:  J Clin Invest       Date:  2009-05       Impact factor: 14.808

9.  Anticomplement therapy.

Authors:  Prathit A Kulkarni; Vahid Afshar-Kharghan
Journal:  Biologics       Date:  2008-12

10.  Novel targets for immunotherapy in glomerulonephritis.

Authors:  Mary H Foster
Journal:  Biologics       Date:  2008-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.